Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
The US Food and Drug Administration (US FDA) has released a detailed report on six observations it reported following a recent inspection at Sun Pharmaceutical ... a Field Alert for Product ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
The Central Drugs Standard Control Organisation (CDSCO) has issued an alert against 58 samples of commonly used medicines as they failed the latest drug safety alert issued by the drug regulator ...
Nimesulide, a commonly used painkiller can cause adverse reactions, as per the IPC alert. Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID ... Ajanta Pharma, Cipla, Sun Pharma, Ipca ...
New Delhi: In its latest drug safety alert, the apex drug regulatory body ... Miconazole Nitrate and Fluocinolone Acetonide Ointment (Zole - F) manufactured by Sun Pharmaceuticals and others. In ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...